Research

SimHealth is being developed for supervised evaluation: feasibility first, then expansion only if safety, governance, and oversight are in place.

Stage: Pre-pilot / pilot planning No medical claims. Outcomes will only be communicated publicly when supported by appropriate evaluation.

Request pilot information Methodology Outcomes

Rationale

SimHealth is being designed as a structured digital companion for high-risk moments (for example: urges, stress spikes, or “just one bet” thoughts), with the goal of improving continuity between clinical sessions.

The research programme is intentionally conservative: the aim is to test feasibility, safety and acceptability first, rather than making claims about clinical outcomes before appropriate evaluation.

Terminology: “UX” means user experience — the usability and clarity of the interface, especially in vulnerable or high-stress moments.

Methodology

SimHealth is intended for staged evaluation — beginning with small supervised pilots and progressing only when safety, governance, and clinical oversight are established. The focus is careful iteration, not uncontrolled release.

Staged evaluation plan

Phase 0 — Feasibility design: safety-first UX, crisis signposting, consent flows, governance documentation.
Phase 1 — Supervised pilot: small cohort, clinician oversight, feasibility + safety signals.
Phase 2 — Expanded evaluation (if justified): broader study design and formal oversight as required.

Data handling (privacy-first)

Where data collection is part of a pilot, it is intended to be optional and used only with explicit participant consent. Collection should be limited to what is necessary for evaluation and improvement, aligned with GDPR principles.

Consent-led: opt-in participation and clear explanations.
Data minimisation: collect the minimum necessary; avoid unnecessary identifiers.
Protection: anonymise where feasible; otherwise pseudonymise and restrict access.
Purpose limitation: no secondary use without appropriate governance.

Clinical boundary: SimHealth is not emergency or crisis care. If crisis risk is present, the correct response is real-world emergency and crisis services.

Outcomes

No outcomes are claimed at this stage. Reporting will be conservative and based on appropriate evaluation. Early work focuses on feasibility, safety and engagement.

Early evaluation signals

Feasibility: safe and consistent use in real pathways.
Acceptability: user experience and clinician fit.
Engagement: continuity between sessions (without coercion).
Safety signals: identification of risk and appropriate signposting.
Clinical usability: minimal burden and clear governance boundaries.

Reporting commitment: Any future outcome discussion will distinguish feasibility/safety findings from clinical effectiveness, and will be shared only when supported by appropriate study design and oversight.

Request pilot information Research enquiries Back to Home